Prof. Arndt Rolfs, Md

Biography

Arndt, founder of CENTOGENE, serves as CEO, bringing in extensive medical and scientific expertise. He is Professor for Neurology at the University of Rostock, Germany and Director of the Albrecht-Kossel-Institute for Neuroregeneration. INFO(AT)CENTOGENE(DOT)COM Read more about Arndt Rolfs  Arndt received his approbation (German official license to practice as a doctor) for human medicine from the Universities of Mainz and Vienna in 1985, and was granted a tenure track professorship for clinical neurology in 1997. He worked at the Department of Neurology and served as head of the Laboratory for Neurochemistry at the Free University of Berlin, at the Max Planck Institute for Molecular Genetics and at the psychiatric clinic of the University Hospital Rudolf-Virchow in Berlin. Since 1998 he has been the Head of the Neurobiological Research Laboratory and Vice-Director of the Neurological clinic and outpatients department at the University of Rostock. In 2008, Arndt was appointed Director of the Albrecht-Kossel-Institute for Neuroregeneration at the University of Rostock. Arndt is a principal investigator of several international multicenter studies in the area of rare diseases, including the Sifap project (www.sifap.eu), the world's largest study in young stroke patients related to Fabry disease, several biomarker studies (e.g. BioGaucher, BioHunter, BioMorquio) and epidemiological studies in neurogenetic aetiologies. Arndt has an extensive track record in medical and scientific publications, acts as a consultant for international biotech and industrial companies, and is also a consultant for the EMA and FDA. Arndt is co-founder of the biotech companies Arcensus AG and Genebanking, and is a major shareholder of CENTOGENE.

Research Interest

Business